Cellular-scale boron distribution in tumour and normal tissue

45

No. 899 in all physics · No. 43 in Medical and Radiation Physics

Non-expert version

Measure the B-10 concentration distribution at 1 to 10 micron resolution in tumour, tumour margin and normal tissue for the clinical carriers (boronophenylalanine and sodium borocaptate), including the fraction of tumour cells with low uptake, and convert it into a microdosimetric specific-energy distribution for the $\alpha$ and Li-7 fragments of ranges about 9 and 5 micron. An answer is a measured distribution and the resulting ratio of cellular to bulk-averaged dose.

What would settle it

Neutron autoradiography or secondary-ion mass spectrometry on biopsy samples taken at treatment time, combined with track-level dose calculation.

No solutions, ideas or subproblems yet.

How results are checked

See also

Comments (0)

Comments are not records: they are not signed, stamped or logged. How comments work

No comments yet.

Sign in to comment.

Details, signature and history
Kind
Well-posed question
Answer
Value
Topic review
Suzuki, Boron neutron capture therapy (BNCT): a unique role in radiotherapy with a view to entering the accelerator-based BNCT era, International Journal of Clinical Oncology, 2020. Link
Record
Revision 1 · imported from the seed collection · compiled by AI, not yet reviewed by an editor

Proof

Fingerprint
d29436889344…
Public log
Entry 1,666, in checkpoint 2,123
In the log by
Block 969,698, 2026-10-03

This text was in the PubPhys log by that date. The date says nothing about when the problem was first posed.

History